Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

save search

Avera Health and Theralink® Technologies Announce Strategic Collaboration to Accelerate Adoption of Precision Oncology and Personalized Cancer Care
Published: 2022-03-28 (Crawled : 17:00) - biospace.com/
THER | $0.003 0 twitter stocktwits trandingview |
n/a
| | O: -80.0% H: 400.0% C: 300.0%

theralink health care collaboration cancer
Auris Medical Reports Positive In vitro Efficacy Data for AM-301 in Protecting Against Sars-CoV-2 Infection
Published: 2020-12-01 (Crawled : 22:08) - globenewswire.com
EARS | $3.02 0% twitter stocktwits trandingview |
Health Technology
| | O: 31.53% H: 352.05% C: 258.22%

positive injection sars-cov-2 infections
Huadi International Group Co., Ltd. Announces Strategic Plan to Enter New Energy Industry, Initiates Discussion with a Sichuan Local Government to Invest and Construct New Energy Battery and Storage Project
Published: 2022-11-03 (Crawled : 13:00) - globenewswire.com
HUDI | $5.56 -1.24% -1.26% 200K twitter stocktwits trandingview |
| | O: 18.23% H: 269.11% C: 200.17%

battery energy international group
Q BioMed announces publication of pre-clinical research showing superior safety and efficacy against current first line therapy of its drug candidate Uttroside-B for liver cancer
Published: 2022-07-26 (Crawled : 13:20) - biospace.com/
QBIO | $0.0095 0 twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 0.25% H: 200.0% C: 200.0%

drug candidate research liver pre-clinical for therapy cancer publication
SHAREHOLDER’S UPDATE — OCTOBER 27, 2022
Published: 2022-10-27 (Crawled : 16:00) - dbmmgroup.com
DBMM | $0.0143 0 twitter stocktwits trandingview |
Manufacturing
| | O: 0.0% H: 200.0% C: 200.0%

update
Sharps Compliance To Be Acquired By an Affiliate of Aurora Capital Partners
Published: 2022-07-12 (Crawled : 14:20) - globenewswire.com
SMED | $8.75 0.0% twitter stocktwits trandingview |
Industrial Services
| | O: -0.35% H: 199.65% C: 197.18%

acquired
NewAge, Inc. Announces That Its Common Stock Has Ceased Trading on Nasdaq
Published: 2022-09-08 (Crawled : 20:00) - globenewswire.com
NBEV | News | $0.065 twitter stocktwits trandingview |
Consumer Non-Durables
| | O: -76.47% H: 217.73% C: 195.45%

nasdaq
GZ6G Technologies Forms Strategic Alliance With Major League Baseball’s Texas Rangers
Published: 2022-09-07 (Crawled : 11:00) - globenewswire.com
GZIC | $0.0068 0 twitter stocktwits trandingview |
| | O: 14.0% H: 244.21% C: 188.77%


NeuroSense Therapeutics Receives FDA Clearance of IND for PrimeC for the Treatment of ALS
Published: 2022-03-21 (Crawled : 13:00) - biospace.com/
NRSN | $1.67 0.6% 0.6% 110K twitter stocktwits trandingview |
| | O: 39.74% H: 275.23% C: 185.78%

treatment fda als clearance therapeutics fda clearance primec for
iFresh Announces NASDAQ Delisting
Published: 2021-11-22 (Crawled : 19:00) - globenewswire.com
IFMK | $0.0105 twitter stocktwits trandingview |
Retail Trade
| | O: -74.5% H: 292.08% C: 180.0%

nasdaq
ANCHIANO INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Anchiano Therapeutics Ltd. - ANCN
Published: 2021-02-09 (Crawled : 21:08) - prnewswire.com
ANCN | $75.36 0% twitter stocktwits trandingview |
Health Technology
| | O: 2.14% H: 268.88% C: 178.32%

merge
Pharvaris Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-12-08 (Crawled : 12:00) - globenewswire.com
PHVS | $9.51 0.96% 0.95% 38K twitter stocktwits trandingview |
| | O: 82.97% H: 184.96% C: 173.51%

financial update results
Pharvaris Announces Positive Top-line Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks
Published: 2022-12-08 (Crawled : 12:00) - globenewswire.com
PHVS | $9.51 0.96% 0.95% 38K twitter stocktwits trandingview |
| | O: 82.97% H: 184.96% C: 173.51%

phvs416 treatment for positive study
Precipio Launches its Rapid COVID-19 Antibody test on Amazon Platform
Published: 2021-05-03 (Crawled : 14:00) - globenewswire.com
PRPO P | $0.8859 0.1% 0.1% 63K twitter stocktwits trandingview |
Health Technology
| | O: 1.1% H: 169.02% C: 169.02%

covid test antibody amazon covid-19
Phio Pharmaceuticals Presents Positive New Data on PH-894 Demonstrating Antitumor Efficacy in Model of PD-1 Refractory Disease at the AACR Annual Meeting 2022
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
PHIO | $6.25 -8.73% -9.57% 91K twitter stocktwits trandingview |
Health Technology
| | O: -2.94% H: 175.0% C: 167.05%

ph-894 disease positive ph94
ReShape Lifesciences Inc. to Merge With Obalon Therapeutics, Inc. to Expand Weight Loss Product Offering
Published: 2021-01-20 (Crawled : 00:00) - biospace.com/
OBLN | $3.05 0% twitter stocktwits trandingview |
Health Technology
| | O: 99.38% H: 235.51% C: 157.94%

weight loss offering merge
Second Sight Medical Products, Inc. Receives FDA Approval for the Argus 2s Retinal Prosthesis System
Published: 2021-03-05 (Crawled : 15:00) - biospace.com/
EYES 4 | $4.14 -0.24% 3.14% twitter stocktwits trandingview |
Health Technology
| | O: 60.14% H: 331.88% C: 152.84%

fda fda approval retina approval
Gritstone Advances Second Generation COVID-19 Vaccine “CORAL” Program with Support from NIAID; Program has Potential to Protect Against Mutant Variants of SARS-CoV-2
Published: 2021-01-19 (Crawled : 11:01) - globenewswire.com
GRTS | $3.23 6.25% 5.88% 1M twitter stocktwits trandingview |
Health Technology
| | O: 38.34% H: 154.19% C: 151.92%

covid vaccine potential sars-cov-2 program
Society Pass (SoPa) Announces Addition to the Russell 2000® Index
Published: 2021-12-19 (Crawled : 00:00) - globenewswire.com
SOPA | $1.035 2.23% 2.18% 330K twitter stocktwits trandingview |
| | O: 36.25% H: 198.89% C: 149.67%

2000 index
NeuroMetrix Receives FDA Breakthrough Device Designation for Treatment of Fibromyalgia with its Wearable Neurostimulation Technology
Published: 2021-07-20 (Crawled : 16:00) - biospace.com/
NURO | $1.9 3.26% 3.16% 39K twitter stocktwits trandingview |
Health Technology
| | O: 23.62% H: 197.77% C: 149.13%

treatment fda device technology fibromyalgia designation
Gainers vs Losers
66% 34%

Top 10 Gainers

Your saved searches
Save your searches and get alerts when important news are released.